Pathology and Microbiology; Haematology/Oncology
Waldenstrom's macroglobulinemia (WM) is a rare condition, accounting for approximately 2% of haematologic malignancies. The most common causes of death in these patients are progression of the malignant lymphoproliferative process, infection and cardiac failure. Acute leukemia is a rare event in the clinical course of WM. A number of case reports have documented the development of terminal acute leukemia in patients with WM following prolonged chemotherapy.
Publication ( Name of Journal)
Journal of Pakistan Medical Association
(2006). Waldenstrom's macroglobulinemia terminating in acute myeloid leukemia. Journal of Pakistan Medical Association, 56(6), 291-292.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_pathol_microbiol/549